Rebecca Taub, Director at MADRIGAL PHARMACEUTICALS, INC. (MDGL), sold 491 shares at $431.94 ($212K) on 2026-03-06, disclosed to the SEC on 2026-03-06.
Open-market sale of $212k MDGL by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| MDGL | SELL | 2026-01-13 | $242K | — | Filing → |
| MDGL | SELL | 2026-01-13 | $18.9M | — | Filing → |
| MDGL | SELL | 2025-12-12 | $20.5M | — | Filing → |